Merck & Co. v. International Chemical Workers Union Council of the United Food & Commercial Workers Union, Local 94C

335 F. App'x 300
CourtCourt of Appeals for the Fourth Circuit
DecidedJuly 6, 2009
Docket08-1917
StatusUnpublished
Cited by2 cases

This text of 335 F. App'x 300 (Merck & Co. v. International Chemical Workers Union Council of the United Food & Commercial Workers Union, Local 94C) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Merck & Co. v. International Chemical Workers Union Council of the United Food & Commercial Workers Union, Local 94C, 335 F. App'x 300 (4th Cir. 2009).

Opinion

Reversed and remanded by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit.

PER CURIAM:

The International Chemical Workers Union Council of the United Food and Commercial Workers Union, Local 94C *301 (the “Union”), appeals from the district court’s adverse decision of August 12, 2008, awarding summary judgment to Merck & Company, Incorporated (“Merck”), and vacating an arbitration award in favor of the Union. See Merck & Co., Inc. v. Int’l Chem. Workers Union Council of the United Food and Commercial Workers Union, Local 94C, No. 5:07— cv-00114, 2008 WL 3485585 (W.D.Va. Aug. 12, 2008) (the “Memorandum Opinion”). 1 The court ruled that the arbitrator had exceeded his authority in making the arbitration award, which required Merck to reinstate one of its employees. As explained below, we reverse and remand for enforcement of the award.

I.

A.

On September 7, 2005, Dale Moubray reported to work at Merck’s Elkton, Virginia, facility under the influence of alcohol. Moubray, a pipe-fitter/millwright, is represented by the Union, which is the exclusive collective bargaining representative for a bargaining unit of production and maintenance employees at Merck’s Elkton facility. 2 Rather than terminate Moubray from his employment, Merck imposed a five-day unpaid disciplinary suspension. Following the suspension, on September 13, 2005, Merck, Moubray, and a Union representative entered into a “Return to Work & Last Chance Agreement” (the “Last Chance Agreement” or the “LCA”). See J.A. 58-59.

The Last Chance Agreement required Moubray to, inter alia, meet with a representative of Merck’s Employee Assistance Plan in order to establish a treatment plan. The LCA further obliged Moubray “to comply with all recommendations and requirements as established by the Employee Assistance Plan and the Health Services Department.” J.A. 58. If, at any time, Moubray failed to comply with these recommendations and requirements, the LCA provided that he would “be subject to immediate termination and such termination [would] not be subject to the contractual grievance and arbitration procedures.” Id. at 59. 3 The LCA stated, however, “that in the event of a termination, Mr. Moubray may file a grievance challenging the facts upon which the Company determined that Mr. Moubray was non-compliant or otherwise in violation of this Agreement.” Id.

On the following day, September 14, 2005, Martha Sheridan, a representative of Merck’s employee assistance program, met with Moubray and decided that he was to participate in a program offered by an independent entity called the LIFE Recovery Program (the “Program”). At his first session in the Program, on September 19, 2005, Moubray executed a patient contract (the “Program Contract”), agreeing to the following relevant conditions:

1. I will attend the LIFE Recovery Program ... Monday, Tuesday, Thursday. ... If extraordinary circumstances prevent my attendance or results in tardiness, I will notify the staff immediately.
*302 7. I will follow all relevant patient rules and regulations as stated in patient handbook. 4
11. I understand that the following behaviors may result in premature discharge from the program:
5. Lack of cooperation with program expectations to the extent of impeding progress (This includes chronic tardiness or absenteeism).

J.A. 62.

In the weeks following the Program’s first session, Moubray attended ten of eleven sessions, with a single excused absence on September 22, 2005. He then missed a session on October 13, 2005, attended sessions on October 17, 2005 and October 24, 2005, and missed sessions on October 18 and October 25, 2005. Mou-bray did not, prior to any of the three missed sessions, notify the Program to explain his absence or request to be excused. Moubray returned for a session on October 27, 2005, and met with his Program case manager, Dee Michael. Michael advised him not to miss the October 31, 2005 session, even though Moubray requested to be excused from it to take his godson trick-or-treating. Despite Michael’s warning, Moubray did not attend the October 31 session. Moubray returned for the session of November 1, 2005, and was advised that he could not continue with the Program until he met with Michael. Moubray called Michael on November 2, 2005, and scheduled an appointment for the following day. Also on November 2, Sheridan, Merck’s employee assistance program representative, called Michael to check on Moubray’s status in the Program. Michael summarized Moubray’s participation, and on November 3, 2005, sent a confirming letter to Merck (the “Letter”). Michael’s Letter concluded: “As of today’s date, Mr. Moubray is not in compliance with our program requirements.” J.A. 69.

Upon Merck’s receipt of the Letter, Sheridan instructed Moubray not to attend the November 3, 2005 meeting with Michael because he had been kicked out of the Program. That same day, Merck notified Moubray by letter that he was out of compliance with the Last Chance Agreement and was, therefore, being suspended from employment, with intent to discharge. On November 14, 2005, Moubray was discharged by Merck.

B.

On November 15, 2005, the Union filed a grievance with Merck, protesting Mou-bray’s discharge and seeking his reinstatement. Merck conducted a grievance hearing on December 16, 2005, and, that same day, denied the Union’s grievance. The Union then submitted its grievance to arbitration before the Federal Mediation and Conciliation Service, on whether Moubray had complied with the terms of the Last Chance Agreement. On August 8, 2007, the parties participated in an arbitration hearing conducted by Arbitrator Jeffrey B. Tener (the “Arbitrator”). Two months later, on October 19, 2006, the Arbitrator entered an Arbitration Opinion and Award (the “Award”), 5 concluding that, although Merck was entitled to terminate Moubray if he was out of compliance with the Last Chance Agreement, “[i]t cannot be concluded that Moubray was not compliant *303 with the conditions of the last [chance] agreement so he was not subject to immediate termination.” Award 20. The Award thus directed Merck to “reinstate [Moubray] to his former position and to make [him] whole.” Id. When Merck refused to accept the Award and reinstate Moubray, this litigation ensued.

Two months later, on December 26, 2007, Merck filed its complaint in the Western District of Virginia, pursuant to § 301 of the Labor Management Relations Act, 29 U.S.C. § 185, seeking to vacate the Award. Merck alleged that the Arbitrator had ignored the plain language of the Last Chance Agreement and that the Award failed to draw its essence from the LCA.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Vogel v. Gracias Juan, LLC
E.D. Virginia, 2022
DeGrandis v. Children's Hospital Boston
806 F.3d 13 (First Circuit, 2015)

Cite This Page — Counsel Stack

Bluebook (online)
335 F. App'x 300, Counsel Stack Legal Research, https://law.counselstack.com/opinion/merck-co-v-international-chemical-workers-union-council-of-the-united-ca4-2009.